DK0722724T3 - Anvendelse af L-carnitin og dets derivater til nedsættelse af de toksiske virkninger af cyclosporin-A og andre immunosuppre - Google Patents

Anvendelse af L-carnitin og dets derivater til nedsættelse af de toksiske virkninger af cyclosporin-A og andre immunosuppre

Info

Publication number
DK0722724T3
DK0722724T3 DK95120394T DK95120394T DK0722724T3 DK 0722724 T3 DK0722724 T3 DK 0722724T3 DK 95120394 T DK95120394 T DK 95120394T DK 95120394 T DK95120394 T DK 95120394T DK 0722724 T3 DK0722724 T3 DK 0722724T3
Authority
DK
Denmark
Prior art keywords
carnitine
cyclosporin
immunosuppressants
derivatives
reduce
Prior art date
Application number
DK95120394T
Other languages
Danish (da)
English (en)
Inventor
Menotti Calvani
Luigi Mosconi
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK0722724T3 publication Critical patent/DK0722724T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/34—Preparation of optical isomers by separation of optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK95120394T 1995-01-20 1995-12-22 Anvendelse af L-carnitin og dets derivater til nedsættelse af de toksiske virkninger af cyclosporin-A og andre immunosuppre DK0722724T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000037A IT1277147B1 (it) 1995-01-20 1995-01-20 Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.

Publications (1)

Publication Number Publication Date
DK0722724T3 true DK0722724T3 (da) 1999-10-11

Family

ID=11402949

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95120394T DK0722724T3 (da) 1995-01-20 1995-12-22 Anvendelse af L-carnitin og dets derivater til nedsættelse af de toksiske virkninger af cyclosporin-A og andre immunosuppre

Country Status (13)

Country Link
US (2) US5955424A (xx)
EP (1) EP0722724B1 (xx)
JP (1) JPH08231390A (xx)
KR (1) KR100443730B1 (xx)
AT (1) ATE177946T1 (xx)
CA (1) CA2167456A1 (xx)
DE (1) DE69508551T2 (xx)
DK (1) DK0722724T3 (xx)
ES (1) ES2130509T3 (xx)
GR (1) GR3030545T3 (xx)
IT (1) IT1277147B1 (xx)
TW (1) TW445145B (xx)
ZA (1) ZA96431B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA65587C2 (en) * 1997-10-09 2004-04-15 Baker Norton Pharma Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
EP1330254B1 (en) * 2000-10-12 2005-07-06 Pharma Mar, S.A. Treatment of cancers by aplidine in conjunction with carnitine or acetylcarnitine
ITRM20010293A1 (it) * 2001-05-29 2002-11-29 Sigma Tau Ind Farmaceuti Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US20070087975A1 (en) * 2005-10-17 2007-04-19 Sigma-Tau Industrie Farmaceutiche Riunite Spa Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
CN102038671B (zh) * 2010-06-29 2012-07-04 辽宁思百得医药科技有限公司 包含左卡尼汀和羟苯磺酸盐的药物组合物
KR101760510B1 (ko) 2014-12-18 2017-07-21 가톨릭대학교 산학협력단 메트포민을 포함하는 면역억제제로 인한 신장 독성 완화용 조성물 및 이를 포함하는 면역질환 예방 또는 치료용 조성물
WO2016099214A1 (ko) * 2014-12-18 2016-06-23 가톨릭대학교 산학협력단 메트포민을 포함하는 면역억제제로 인한 신장 독성 완화용 조성물 및 이를 포함하는 면역질환 예방 또는 치료용 조성물
IT201900007446A1 (it) * 2019-05-29 2020-11-29 Giuseppe Castellano Composizione comprendente citrato e carnitina in grado di attivare la produzione della proteina klotho
CN115469026B (zh) * 2022-07-14 2023-10-20 中日友好医院(中日友好临床医学研究所) 用于检测环孢素a肾毒性相关标志物的检测试剂、试剂盒及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1195852B (it) * 1986-07-04 1988-10-27 Sigma Tau Ind Farmaceuti Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati
JPH01213258A (ja) * 1988-02-23 1989-08-28 Kyowa Hakko Kogyo Co Ltd カルニチンおよびカルニチンアミドの精製法

Also Published As

Publication number Publication date
CA2167456A1 (en) 1996-07-21
ATE177946T1 (de) 1999-04-15
JPH08231390A (ja) 1996-09-10
TW445145B (en) 2001-07-11
ITRM950037A1 (it) 1996-07-20
DE69508551T2 (de) 1999-09-02
ES2130509T3 (es) 1999-07-01
KR960029314A (ko) 1996-08-17
EP0722724B1 (en) 1999-03-24
GR3030545T3 (en) 1999-10-29
DE69508551D1 (de) 1999-04-29
ZA96431B (en) 1996-08-08
KR100443730B1 (ko) 2004-10-14
ITRM950037A0 (it) 1995-01-20
US5958941A (en) 1999-09-28
EP0722724A1 (en) 1996-07-24
US5955424A (en) 1999-09-21
IT1277147B1 (it) 1997-11-04

Similar Documents

Publication Publication Date Title
CA2183655A1 (en) 4-polycyclic amino-substituted quinazoline derivatives
CA2216796A1 (en) Quinazoline derivatives
ATE185792T1 (de) Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen
TR199801115T2 (xx) Kinazolin t�revleri.
DK0722724T3 (da) Anvendelse af L-carnitin og dets derivater til nedsættelse af de toksiske virkninger af cyclosporin-A og andre immunosuppre
ES2196331T3 (es) Derivados macrociclicos de cadena de 13 elementos de las eritromicinas a y b.
EP0630898A4 (en) MEDICINE FOR THROMBOZYTOPENIA.
KR910019618A (ko) 발기부전증 치료용 제약 조성물
PT876388E (pt) Derivados de eritromicina triciclica
PT921787E (pt) Regime de administracao de inibidores de atpase de h',k'
ES2175614T3 (es) Derivados fluorosustituidos de adamantano.
WO1996030370A3 (en) Thiazole and thiadiazole derivatives, their preparation and pharmaceutical compositions useful in the treatment of thrombocytopenia
DE69824313D1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
TW221441B (xx)
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
DE69600231D1 (de) N-Arylalkylphenylacetamidderivate
ATE237619T1 (de) Sesquiterpen-derivate mit antiviraler aktivität
DE69412612D1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
DK0566288T3 (da) Flavon-derivater
EP0630888A4 (en) IMIDAZOLINE DERIVATIVES, THEIR PRODUCTION AND BLOOD PRESSURE HOLDERS.
TH53868A3 (th) สารประกอบอะซาโพลีไซคลิกที่ถูกเชื่อมประสานของอะรีล